凱萊英(002821.SZ):引入高瓴資本作為戰投
格隆匯5月13日丨凱萊英(002821.SZ)此前公告,擬非公開發行A股股票,募集資金總額預計不超過23.11億元,發行股份不超過1870萬股(含1870萬股);本次非公開發行的定價基準日為第三屆董事會第三十三次會議決議公告日,發行價格不低於定價基準日前二十個交易日公司股票交易均價的80%(定價基準日前20個交易日公司股票交易均價=定價基準日前20個交易日股票交易總額/定價基準日前20個交易日股票交易總量),發行價格為123.56元/股。本次非公開發行的戰略投資對象為高瓴資本管理有限公司。
公司於2020年5月12日第三屆董事會第三十六次會議審議通過了《關於公司引入戰略投資者的議案》《關於公司與戰略投資者簽訂附條件生效的戰略合作協議的議案》,公司擬根據本次非公開發行股票的方案,引入高瓴資本管理有限公司作為戰略投資者,並與其簽署附條件生效戰略合作協議。
高瓴資本依託在全球創新藥市場的投資佈局,積極推動上市公司顯著提升服務創新藥公司的廣度和深度,在小分子、核酸、生物藥 CDMO 以及創新藥臨牀研究服務等公司新業務領域開展深入戰略合作。高瓴資本通過推動高瓴被投企業與凱萊英建立合作關係,以及通過行業內的資源網絡推動製藥公司與凱萊英建立合作關係。
該合作期限為協議生效之日起三十六個月。在協議生效後的戰略合作期內,為甲方帶來訂單累計不低於人民幣 8 億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.